Table 2.
Tumor characteristics of 113 patients treated with TPFa induction chemotherapy for locally advanced head and neck cancer
| Squamous cell carcinoma – no. (%) | 102 (90) |
| Primary disease site – no. (%) | |
| Oral cavity | 7 (6) |
| Oropharynx | 26 (23) |
| Nasosinus | 11 (10) |
| Nasopharynx | 10 (9) |
| Hypopharynx | 27 (24) |
| Larynx | 31 (27) |
| Adenopathy without primitif | 1 (1) |
| Laryngeal preservation – no. (%) | 44 (39) |
| Stage – no. (%) | |
| II | 2 (2) |
| III | 32 (28) |
| IVA | 51 (45) |
| IVB | 28 (25) |
| Tumor size – no. (%) | |
| T1 | 3 (3) |
| T2 | 15 (13) |
| T3 | 52 (46) |
| T4 | 42 (37) |
| Tx | 1 (1) |
| Nodal status – no. (%) | |
| N0 | 26 (23) |
| N1 | 13 (11) |
| N2 | 53 (47) |
| N3 | 21 (19) |
aTPF docetaxel, cisplatin, 5-fluorouracil